TrialThe international journal of cardiovascular imaging2013

Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial.

Rami Doukky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.